News

All Content

Study Links Early Sleep Problems to Autism Diagnosis Among At-Risk Children

Previous research has shown that young children who have a sibling with ASD are at a higher risk for also being diagnosed with the condition.

Experts Urge Continued Immunizations During COVID-19 Pandemic

Organizations have warned that disruptions in immunization services could lead to outbreaks in many vaccine-preventable diseases.

Study: More Berries, Apples, Tea May Have Protective Benefits Against Alzheimer

Researchers examined the long-term relationship between eating foods containing flavonoids and the risk of AD and AD-related dementias (ADRD).

COVID-19 Pandemic Transforms Use of Telemedicine Resources, Potentially for the Foreseeable Future

Virtual urgent care visits at NYU Langone Health increased by 683%, and nonurgent virtual care visits increased by 4345% based on daily averages.

World Asthma Day 2020 Recognizes COVID-19 Pandemic

The National Institutes of Health (NIH) has issued a timely statement emphasizing the importance of asthma awareness and standing with parents, families, advocates, researchers, and health care professionals.

New Study Seeks to Determine Incidence Rate of COVID-19 in Children

A study to help determine the incidence rate of the coronavirus disease 2019 (COVID-19) in children and their family members has begun enrolling participants in the United States, according to the National Institutes of Health (NIH).

$10B Rural Relief Fund for COVID-19 Providing Assistance to Clinics, Hospitals

As the COVID-19 pandemic has spread to more communities, hundreds of rural hospitals, health clinics, and small physician practices are on the verge of closure.

Study: Dietary Counseling Introduced at Early Age Leads to Better Cardiovascular Health in Adulthood

The STRIP examined the benefits of promoting cardiovascular health by dietary counseling from infancy to early adulthood.

FDA Approved Efinaconazole for Children with Toenail Fungal Infection

Efinaconazole was first approved by the FDA in June 2014 for patients 18 and older.

Remdesivir Trial Demonstrates Positive Results for Patients with COVID-19

Remdesivir is not approved by the FDA nor licensed or approved anywhere in the world.